HEALTH PROBLEMS — CANCER

SORT date author clear filters


FILTER RECORDS BY


Trotta F, Apolone G, Garattini S, Tafuri G (2008)
Stopping a trial early in oncology: for patients or for industry? Annals of Oncology Feb 29; doi:10.1093/annonc/mdn042.

View

Djulbegovic B, Kumar A, Soares HP, Hozo I, Bepler G, Clarke M, Bennett CL (2008)
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the national cancer institute-sponsored cooperative oncology groups, 1955 to 2006. Archives of Internal Medicine. 168:632-42.

View

Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, Kuderer NM, Lyman GH (2000)
The uncertainty principle and industry-sponsored research. Lancet 356:635-638.

View

Rimer BK, Resch N, King E, Ross E, Lerman C, Boyce A, Engstrom PF (1992)
Multistrategy health education program to increase mammography use among women ages 65 and older. Public Health Reports 107:369-380.

View

Advanced Ovarian Cancer Trialists Group (1991)
Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. BMJ 303:884-893.

View

Gray R, Wheatley K (1991)
How to avoid bias when comparing bone marrow transplantation with chemotherapy. Proceedings of the International Course on Bone Marrow Transplantation in Children, 28 Nov-1 Dec 1990, Erice, Italy. Bone Marrow Transplantation 7, Suppl 3:9-12.

View

Early Breast Cancer Trialists' Collaborative Group (1990)
Treatment of early breast cancer. Vol 1. Worldwide evidence, 1985-1990. Oxford: Oxford University Press.

View

Worden JK, Solomon LJ, Flynn BS, Costanza MC, Foster RS, Dorwaldt AL, Weaver SO (1990)
A community-wide program in breast self-examination training and maintenance. Preventive Medicine 19;254-269.

View

Early Breast Cancer Trialists' Collaborative Group (1988)
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. New England Journal of Medicine 319:1681-92.

View

Mayer JA, Dubbert PM, Scott RR, Dawson BL, Ekstrand ML, Fondren TG (1987)
Breast self-examination: The effects of personalized prompts on practice frequency. Behavior Therapy 18:135-46.

View

Yusuf S, Simon R, Ellenberg SS (1987)
Proceedings of the workshop on methodologic issues in overviews of randomized clinical trials, May 1986. Statistics in Medicine 6:217-409.

View

Himel HN, Liberati A, Gelber RD, Chalmers TC (1986)
Adjuvant chemotherapy for breast cancer: A pooled estimate based on results from published randomized control trials. JAMA 256:1148-1159.

View

Peto J, Eden OB, Lilleyman J, Richards S (1986)
Improvement in treatments for children with acute lymphoblastic leukaemia: The Medical Research Council UKALL Trials, 1972-84. Lancet 1:408-411.

View

Simes RJ (1986)
Publication bias: the case for an international registry of clinical trials. Journal of Clinical Oncology 4:1529-41.

View

Tabár L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Gröntoft O, Ljungquist U, Lundström B, Månson JC, Eklund G, Day NE, Pettersson F (1985)
Reduction in mortality from breast cancer after mass screening with mammography Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 13;1:829-32.

View

Roberts MM, Alexander FE, Anderson TJ, Forrest APM, Hepburn W, Huggins A, Kirkpatrick AE, Lamb J, Lutz W, Muir BB (1984)
The Edinburgh randomised trial of screening for breast cancer: Description of method. British Journal of Cancer 50:1-6.

View

Foon KA, Smalley RV, Riggs CW, Gale RP (1983)
The role of immunotherapy in acute myelogenous leukemia. Arch Intern Med 143: 1726-1731

View

Pocock SJ (1977)
Randomised clinical trials. BMJ 1:1661.

View

Colombo F, Shapiro S, Slone D, Tognoni G (1977)
Epidemiological evaluation of drugs. Amsterdam: Elsevier/North-Holland Biomedical Press.

View

Levitt SH, McHugh RB, Song CW (1976)
Radiotheraphy in the postoperative treatment of operable cancer of the breast. Part II. A re-examination of Stjernsward’s application of the Mantel-Haenszel statistical method. Evaluation of the effect of the radiation on immune response and suggestions for postoperative radiotherapy. Cancer 39:933-940.

View

Stjernswärd J (1974)
Decreased survival related to irradiation postoperatively in early breast cancer. Lancet 304:1285-1286.

View

Schneiderman MA (1966)
Therapeutic trials in cancer. Working paper prepared for WHO Expert Committee on Cancer Treatment, Geneva, Switzerland, 9-15 March 1965. WHO/CANC/66.66.

View

Bross ID (1966)
Spurious effects from an extraneous variable. Journal of Chronic Diseases 19:637-47.

View

Zubrod CG, Schneiderman M, Frei E, Brindley C, Gold GL, Shnider B, Oviedo R, Gorman J, Jones R, Jonsson U, Colsky J, Chalmers T, Ferguson B, Dederick M, Holland J, Selawry O, Regelson W, Lasagna L, Owens AH (1960)
Appraisal of methods for the study of chemotherapy in man: Comparative therapeutic trial of nitrogen mustard and thiophosphoramide. Journal of Chronic Diseases 11:7-33.

View

Witts LJ (1959)
Medical surveys and clinical trials: some methods and applications of group research in medicine. Oxford: Oxford University Press.

View

Merk R (1948)
Die Stickstoffsenfgasbehandlung der Lymphogranulomatose [Nitrogen Mustard Treatment of Lymphogranulomatosis]. Medizinische Klinik 43:629-35.

View

Farber S, Diamond LK, Mercer RD, Sylvester RF, Wolff JA (1948)
Temporary remissions in acute leukaemia in children produced by folic acide antagonist, 4-aminopteroyl-glutamic acid (aminopterin). New England Journal of Medicine 238:787-793.

View

Goodman LS, Wintrobe MM, Dameshek W, Goodman MJ, Gilman A and McLennan MT (1946)
Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. Journal of the American Medical Association 132:126-132.

View

De Quervain JF (1930)
Zusammenfassung der Ergebnisse der schweizerischen Sammelstatistik über Brustkrebs von 1911-1915. [Summary of the results of the aggregated Swiss hospital statistics on breast cancer from 1911-1915]. Bern-Berlin: Huber.

View

Show


Jefferson T (2019).
Sponsorship bias in clinical trials – growing menace or dawning realisation? JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Zwarenstein M (2016).
‘Pragmatic’ and ‘Explanatory’ attitudes to randomized trials. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Peto R (2016).
Reflections on the design and analysis of clinical trials and meta-analyses in the 1970s and 1980s. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Peto J (2016).
Reflections on the importance of strict adherence to treatment protocols: acute lymphoblastic leukaemia in children in the 1970s in the US and the UK. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Stjernswärd J (2013)
Personal reflections on contributions to pain relief, palliative care and global cancer control JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Spain P, Kadan-Lottick N (2010).
Observations of unprecedented remissions following novel treatment for acute leukemia in children in 1948. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2010).
Johann Friedrich de Quervain (1868-1940). Swiss surgical innovator. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Stjernswärd J (2009)
Meta-analysis as a manifestation of ‘bondförnuft’ (‘peasant sense’). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Armitage P† (2003).
Some recollections of the early years of the Medical Research Council (MRC) Statistical Research Unit. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Nothing found, please try resetting your search filters